A pregnancy-related protein, PZP, shows promise as a biomarker for poor survival and immune changes in women with lung adenocarcinoma, says a new study.

We are in the midst of a historic evolution in the study of lung adenocarcinoma, with advances occurring at every level, including pathology, clinical investigation, radiology, molecular biology, and ...

Adenocarcinoma is a cancer that begins in the glandular cells of internal organs, such as the lungs. Non-small cell adenocarcinoma is a common type of lung cancer.

Merus announces FDA approval of Bizengri (zenocutuzumab-zbco) for NRG1+ pancreatic adenocarcinoma and NRG1+ non–small cell lung cancer (NSCLC) based on safety and efficacy data from the eNRGy study.

Background: Fetal adenocarcinoma (FA) is a rare subtype of lung neoplasia whose structure is similar to a developing fetal lung. Chest x-ray is valuable for diagnosis as 25 - 40% of patients with FA ...

Background and objectives Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC ...

Researchers built a new atlas of lung cells, uncovering new cellular pathways and precursors in the development of lung adenocarcinoma, the most common type of lung cancer. These findings open the ...

Tumor genomics and clinicopathologic features better predict recurrent lung adenocarcinoma (LUAD) following primary resection compared with the TNM classification system, according to a recent study ...

Lung Squamous cell carcinoma (LSCC) represents the second most common non-small cell lung cancer. Although studies identified adenocarcinoma-like driver mutations in LSCC using next-generation ...